Celyad Oncology’s $32.5 Million Private Placement With Fortress Investment Group

Skadden, Arps, Slate, Meagher & Flom and Eubelius advised Fortress Investment Group in the transaction. Goodwin Procter and Harvest advised Celyad Oncology.Fortress Investment Group (“Fortress”) announced with…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Laura Testa

Author: Laura Testa

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here